"10.1371_journal.pone.0072185","plos one","2013-08-19T00:00:00Z","Rolf Billeskov; Jan P Christensen; Claus Aagaard; Peter Andersen; Jes Dietrich","Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark; Institute of International Health, Immunology and Microbiology, University of Copenhagen, Denmark","Conceived and designed the experiments: RB JD PA JPC. Performed the experiments: RB. Analyzed the data: RB JD. Contributed reagents/materials/analysis tools: CA. Wrote the paper: RB PA JD.","C.A. and P.A. are co-inventors on a patent WO2006136162 covering the use of H28 as a vaccine. P.A. is a co-inventor of patent WO2006002642 covering the use of CAF01 as an adjuvant. All rights have been assigned to Statens Serum Institut, a Danish not-for-profit governmental institute. This does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Rolf Billeskov","RB",5,TRUE,4,1,2,3,TRUE,TRUE,FALSE,0,NA,FALSE
